Ann: Prospectus for Renounceable Rights Issue, page-10

How did the ASX allow this to happen? 90%+ discount with options that is in the money?

Nevermind that, I am more curious on the strategy to actually survive past this 3m. They will not hit cash flow break even so as a business this is not self sustainable. Only way is to continue raising capital. How? And from where? At what terms? Almost impossible if you ask me. So the coming few months for them is do or die. They need to change something in a big way to survive.

This management, Chair, board, etc unfortunately has turned a very appealing medtech into garbage. I wouldn’t be surprised if there will be a shareholders riot at the door soon.